SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-015144
Filing Date
2023-08-21
Accepted
2023-08-21 17:17:10
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sngx-20230630x10q.htm   iXBRL 10-Q 1790769
2 EX-31.1 sngx-20230630xex31d1.htm EX-31.1 18446
3 EX-31.2 sngx-20230630xex31d2.htm EX-31.2 18504
4 EX-32.1 sngx-20230630xex32d1.htm EX-32.1 8290
5 EX-32.2 sngx-20230630xex32d2.htm EX-32.2 8778
  Complete submission text file 0001558370-23-015144.txt   7436706

Data Files

Seq Description Document Type Size
6 EX-101.SCH sngx-20230630.xsd EX-101.SCH 45358
7 EX-101.CAL sngx-20230630_cal.xml EX-101.CAL 48130
8 EX-101.DEF sngx-20230630_def.xml EX-101.DEF 238992
9 EX-101.LAB sngx-20230630_lab.xml EX-101.LAB 450513
10 EX-101.PRE sngx-20230630_pre.xml EX-101.PRE 354222
55 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20230630x10q_htm.xml XML 1233440
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 231190016
SIC: 2834 Pharmaceutical Preparations